ArticleTherapeutic advances in neurological disorders2023

Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.

Kimberley Allen-Philbey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.